SCHEMBL13065736

SCHEMBL13065736

COc1c2oc3ccccc3nc-2c(C(=O)O)c(-c2ccc(C(=O)O)cc2)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL9 O00512 1/20 0.44
CTNNB1 P35222 1/20 0.44
HPGD P15428 6/20 0.43
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 4/20 0.43
HSD17B10 Q99714 4/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MAPT P10636 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
ABCG2 Q9UNQ0 5/20 0.42
HPSE Q9Y251 1/20 0.42
CYP2C9 P11712 3/20 0.39
CYP2C19 P33261 3/20 0.39
CYP1A2 P05177 2/20 0.39
GFER P55789 1/20 0.39
DHODH Q02127 1/20 0.39
ABCB1 P08183 1/20 0.39
CYP3A4 P08684 2/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065744 0.94 ABCG2 (0.48) HPGDALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL13065739 0.92 ALDH1A1 (0.44) BCL9CTNNB1HPGDALDH1A1KDM4E
SCHEMBL13065730 0.92 ABCG2 (0.50) HPGDALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL13065741 0.91 DHODH (0.47) BCL9CTNNB1HPGDALDH1A1KDM4E
SCHEMBL13065734 0.89 SMN1; SMN2 (0.40) HPGDALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL13065743 0.88 KDM4E (0.40) HPGDALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL13065745 0.88 ABCG2 (0.39) HPGDALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL13065742 0.85 KDM4E (0.47) HPGDALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL13065738 0.85 HPGD (0.42) HPGDALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL13065614 0.84 BCL9 (0.40) BCL9CTNNB1HPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 BCL9 1612/4885CTNNB1 9/4885HPGD 3218/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 BCL9 1612/4885CTNNB1 9/4885HPGD 3218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.